Further studies should be carried out to dissect in detail the complex effects of 2-HG on leukemic cells and on healthy bone marrow cells, and its role in the response of AML blasts to therapies, thus improving the management of R/R AML with mutated IDH enzymes. The gene discussed is IDH1; the disease is acute myeloid leukemia.